Finance
When it comes to claims review, AI allows things to be done much faster than humans with less errors, says Christine Stetler, AVP of Solution Engineering at MedeAnalytics.
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.
The San Francisco-based digital musculoskeletal care company filed to go public on Monday and will list under the ticker symbol HNGE.
The company's population health revenue more than doubled from the $715,000 garnered in 2023. Syra also reported a 45% increase in YOY revenue and a net loss of $3.8 million.
The MSK company will use the funds to expand its value-based care initiatives and advance its technology and clinical programs.
The New York-based company also reported a 110% increase in fourth-quarter revenue in 2024 compared to Q4 2023 and a Q4 2024 net loss of $9.6 million.
The New York-based company posted a net loss of $1 billion, or $5.87 per share, causing its stock price to fall around 15%.
HIMSS25
The cost burden is lowered when rural hospitals share their EHR because the host can bear the cost of things such as infrastructure, security and staffing, says David Winn, vice president for Parkview Community Connect at Parkview Health.
The financing is in addition to a $1.8 million NIH grant for a Veris implantable physiological monitor.
This comes five years after Advent Partners and Geoffrey Sayer, who became its CEO, bought the company.